Learn More
BACKGROUND The epidemiology and pathophysiology of non-erosive gastro-oesophageal reflux disease differs from erosive gastro-oesophageal reflux disease. There is a possibility that non-erosive(More)
BACKGROUND Vonoprazan is a new potassium-competitive acid blocker for treatment of acid-related diseases. AIM To conduct two randomised-controlled trials, to evaluate the non-inferiority of(More)
Because recovery of erectile function and avoidance of positive surgical margins are important but competing outcomes with prostate cancer therapy, the decision to preserve or resect a neurovascular(More)
  • 1